Coexpression	0	12	O
of	13	15	O
vascular	16	24	B-Gene_or_gene_product
endothelial	25	36	I-Gene_or_gene_product
growth	37	43	I-Gene_or_gene_product
factor	44	50	I-Gene_or_gene_product
and	51	54	O
p53	55	58	B-Gene_or_gene_product
protein	59	66	O
in	67	69	O
squamous	70	78	B-Pathological_formation
cell	79	83	I-Pathological_formation
carcinoma	84	93	I-Pathological_formation
of	94	96	O
the	97	100	O
esophagus	101	110	B-Organ
.	110	111	O

OBJECTIVE	113	122	O
:	122	123	O
p53	124	127	B-Gene_or_gene_product
plays	128	133	O
a	134	135	O
role	136	140	O
in	141	143	O
tumor	144	149	B-Pathological_formation
angiogenesis	150	162	O
,	162	163	O
and	164	167	O
vascular	168	176	B-Gene_or_gene_product
endothelial	177	188	I-Gene_or_gene_product
growth	189	195	I-Gene_or_gene_product
factor	196	202	I-Gene_or_gene_product
(	203	204	O
VEGF	204	208	B-Gene_or_gene_product
)	208	209	O
plays	210	215	O
a	216	217	O
key	218	221	O
role	222	226	O
in	227	229	O
tumor	230	235	B-Pathological_formation
angiogenesis	236	248	O
.	248	249	O

The	250	253	O
aim	254	257	O
of	258	260	O
the	261	264	O
present	265	272	O
study	273	278	O
was	279	282	O
to	283	285	O
clarify	286	293	O
how	294	297	O
expression	298	308	O
of	309	311	O
p53	312	315	B-Gene_or_gene_product
protein	316	323	O
participates	324	336	O
in	337	339	O
angiogenesis	340	352	O
,	352	353	O
and	354	357	O
whether	358	365	O
the	366	369	O
coexpression	370	382	O
of	383	385	O
VEGF	386	390	B-Gene_or_gene_product
and	391	394	O
p53	395	398	B-Gene_or_gene_product
protein	399	406	O
has	407	410	O
a	411	412	O
significance	413	425	O
for	426	429	O
angiogenesis	430	442	O
and	443	446	O
the	447	450	O
clinicopathological	451	470	O
features	471	479	O
in	480	482	O
esophageal	483	493	B-Pathological_formation
squamous	494	502	I-Pathological_formation
cell	503	507	I-Pathological_formation
carcinoma	508	517	I-Pathological_formation
(	518	519	O
SCC	519	522	B-Pathological_formation
)	522	523	O
.	523	524	O

METHODS	525	532	O
:	532	533	O
Tissues	534	541	B-Tissue
samples	542	549	I-Tissue
were	550	554	O
taken	555	560	O
from	561	565	O
60	566	568	O
patients	569	577	B-Organism
with	578	582	O
esophageal	583	593	B-Pathological_formation
SCC	594	597	I-Pathological_formation
after	598	603	O
surgery	604	611	O
.	611	612	O

The	613	616	O
expression	617	627	O
of	628	630	O
VEGF	631	635	B-Gene_or_gene_product
and	636	639	O
p53	640	643	B-Gene_or_gene_product
protein	644	651	O
in	652	654	O
these	655	660	O
SCC	661	664	B-Pathological_formation
was	665	668	O
examined	669	677	O
immunohistochemically	678	699	O
.	699	700	O

Microvessel	701	712	B-Tissue
density	713	720	O
(	721	722	O
MVD	722	725	O
)	725	726	O
was	727	730	O
determined	731	741	O
by	742	744	O
counting	745	753	O
microvessels	754	766	B-Tissue
in	767	769	O
tumor	770	775	B-Pathological_formation
sections	776	784	O
stained	785	792	O
for	793	796	O
Factor	797	803	B-Gene_or_gene_product
VIII	804	808	I-Gene_or_gene_product
-	808	809	I-Gene_or_gene_product
related	809	816	I-Gene_or_gene_product
antigen	817	824	I-Gene_or_gene_product
.	824	825	O

Ki	826	828	B-Gene_or_gene_product
-	828	829	I-Gene_or_gene_product
67	829	831	I-Gene_or_gene_product
labeling	832	840	O
index	841	846	O
(	847	848	O
LI	848	850	O
)	850	851	O
was	852	855	O
calculated	856	866	O
,	866	867	O
based	868	873	O
on	874	876	O
Ki	877	879	B-Gene_or_gene_product
-	879	880	I-Gene_or_gene_product
67	880	882	I-Gene_or_gene_product
antigen	883	890	O
immunostaining	891	905	O
,	905	906	O
as	907	909	O
a	910	911	O
proliferative	912	925	O
marker	926	932	O
.	932	933	O

Apoptotic	934	943	O
index	944	949	O
(	950	951	O
AI	951	953	O
)	953	954	O
was	955	958	O
calculated	959	969	O
,	969	970	O
based	971	976	O
on	977	979	O
the	980	983	O
terminal	984	992	B-Gene_or_gene_product
deoxynucleotidyl	993	1009	I-Gene_or_gene_product
transferase	1010	1021	I-Gene_or_gene_product
-	1021	1022	O
mediated	1022	1030	O
deoxyuridine	1031	1043	B-Drug_or_compound
triphosphate	1044	1056	I-Drug_or_compound
biotin	1057	1063	I-Drug_or_compound
nick	1064	1068	O
end	1069	1072	O
labeling	1073	1081	O
,	1081	1082	O
to	1083	1085	O
evaluate	1086	1094	O
apoptosis	1095	1104	O
.	1104	1105	O

RESULTS	1106	1113	O
:	1113	1114	O
VEGF	1115	1119	B-Gene_or_gene_product
expression	1120	1130	O
was	1131	1134	O
observed	1135	1143	O
in	1144	1146	O
58	1147	1149	O
.	1149	1150	O
3	1150	1151	O
%	1151	1152	O
,	1152	1153	O
and	1154	1157	O
p53	1158	1161	B-Gene_or_gene_product
protein	1162	1169	O
expression	1170	1180	O
was	1181	1184	O
observed	1185	1193	O
in	1194	1196	O
61	1197	1199	O
.	1199	1200	O
7	1200	1201	O
%	1201	1202	O
of	1203	1205	O
the	1206	1209	O
60	1210	1212	O
patients	1213	1221	B-Organism
.	1221	1222	O

VEGF	1223	1227	B-Gene_or_gene_product
and	1228	1231	O
p53	1232	1235	B-Gene_or_gene_product
protein	1236	1243	O
were	1244	1248	O
significantly	1249	1262	O
coexpressed	1263	1274	O
in	1275	1277	O
26	1278	1280	O
(	1281	1282	O
43	1282	1284	O
.	1284	1285	O
4	1285	1286	O
%	1286	1287	O
)	1287	1288	O
.	1288	1289	O

Histological	1290	1302	O
venous	1303	1309	B-Multi-tissue_structure
invasion	1310	1318	O
(	1319	1320	O
p	1320	1321	O
less	1323	1327	O
than	1328	1332	O
0	1334	1335	O
.	1335	1336	O
01	1336	1338	O
)	1338	1339	O
and	1340	1343	O
distant	1344	1351	O
metastasis	1352	1362	O
(	1363	1364	O
p	1364	1365	O
less	1367	1371	O
than	1372	1376	O
0	1378	1379	O
.	1379	1380	O
05	1380	1382	O
)	1382	1383	O
were	1384	1388	O
significantly	1389	1402	O
correlated	1403	1413	O
with	1414	1418	O
p53	1419	1422	B-Gene_or_gene_product
protein	1423	1430	O
expression	1431	1441	O
.	1441	1442	O

The	1443	1446	O
two	1447	1450	O
parameters	1451	1461	O
were	1462	1466	O
more	1467	1471	O
frequently	1472	1482	O
observed	1483	1491	O
in	1492	1494	O
the	1495	1498	O
SCC	1499	1502	B-Pathological_formation
with	1503	1507	O
VEGF	1508	1512	B-Gene_or_gene_product
/	1512	1513	O
p53	1513	1516	B-Gene_or_gene_product
coexpression	1517	1529	O
than	1530	1534	O
in	1535	1537	O
those	1538	1543	O
without	1544	1551	O
the	1552	1555	O
coexpression	1556	1568	O
.	1568	1569	O

The	1570	1573	O
MVD	1574	1577	O
and	1578	1581	O
Ki	1582	1584	B-Gene_or_gene_product
-	1584	1585	I-Gene_or_gene_product
67	1585	1587	I-Gene_or_gene_product
LI	1588	1590	O
were	1591	1595	O
significantly	1596	1609	O
higher	1610	1616	O
(	1617	1618	O
p	1618	1619	O
less	1621	1625	O
than	1626	1630	O
0	1632	1633	O
.	1633	1634	O
01	1634	1636	O
and	1637	1640	O
p	1641	1642	O
less	1644	1648	O
than	1649	1653	O
0	1655	1656	O
.	1656	1657	O
001	1657	1660	O
)	1660	1661	O
,	1661	1662	O
and	1663	1666	O
the	1667	1670	O
AI	1671	1673	O
was	1674	1677	O
significantly	1678	1691	O
lower	1692	1697	O
(	1698	1699	O
p	1699	1700	O
less	1702	1706	O
than	1707	1711	O
0	1713	1714	O
.	1714	1715	O
001	1715	1718	O
)	1718	1719	O
in	1720	1722	O
the	1723	1726	O
SCC	1727	1730	B-Pathological_formation
with	1731	1735	O
p53	1736	1739	B-Gene_or_gene_product
protein	1740	1747	O
expression	1748	1758	O
than	1759	1763	O
in	1764	1766	O
the	1767	1770	O
SCC	1771	1774	B-Pathological_formation
without	1775	1782	O
it	1783	1785	O
.	1785	1786	O

The	1787	1790	O
MVD	1791	1794	O
and	1795	1798	O
Ki	1799	1801	B-Gene_or_gene_product
-	1801	1802	I-Gene_or_gene_product
67	1802	1804	I-Gene_or_gene_product
LI	1805	1807	O
were	1808	1812	O
higher	1813	1819	O
,	1819	1820	O
and	1821	1824	O
the	1825	1828	O
AI	1829	1831	O
was	1832	1835	O
lower	1836	1841	O
in	1842	1844	O
the	1845	1848	O
SCC	1849	1852	B-Pathological_formation
with	1853	1857	O
VEGF	1858	1862	B-Gene_or_gene_product
/	1862	1863	O
p53	1863	1866	B-Gene_or_gene_product
coexpression	1867	1879	O
than	1880	1884	O
in	1885	1887	O
those	1888	1893	O
without	1894	1901	O
the	1902	1905	O
coexpression	1906	1918	O
.	1918	1919	O

The	1920	1923	O
5	1924	1925	O
-	1925	1926	O
yr	1926	1928	O
survival	1929	1937	O
rate	1938	1942	O
in	1943	1945	O
patients	1946	1954	B-Organism
with	1955	1959	O
the	1960	1963	O
coexpression	1964	1976	O
was	1977	1980	O
poorer	1981	1987	O
than	1988	1992	O
in	1993	1995	O
the	1996	1999	O
other	2000	2005	O
patients	2006	2014	B-Organism
.	2014	2015	O

CONCLUSION	2016	2026	O
:	2026	2027	O
These	2028	2033	O
results	2034	2041	O
suggest	2042	2049	O
that	2050	2054	O
mutant	2055	2061	O
p53	2062	2065	B-Gene_or_gene_product
expression	2066	2076	O
is	2077	2079	O
associated	2080	2090	O
with	2091	2095	O
angiogenesis	2096	2108	O
and	2109	2112	O
distant	2113	2120	O
metastasis	2121	2131	B-Pathological_formation
in	2132	2134	O
esophageal	2135	2145	B-Pathological_formation
SCC	2146	2149	I-Pathological_formation
,	2149	2150	O
and	2151	2154	O
that	2155	2159	O
the	2160	2163	O
coexpression	2164	2176	O
of	2177	2179	O
p53	2180	2183	B-Gene_or_gene_product
and	2184	2187	O
VEGF	2188	2192	B-Gene_or_gene_product
may	2193	2196	O
play	2197	2201	O
an	2202	2204	O
important	2205	2214	O
role	2215	2219	O
in	2220	2222	O
angiogenesis	2223	2235	O
,	2235	2236	O
and	2237	2240	O
have	2241	2245	O
important	2246	2255	O
clinical	2256	2264	O
significance	2265	2277	O
.	2277	2278	O

